Combination of peroxisome proliferator–activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells-Reference-Cited by-同舟云学术

Combination of peroxisome proliferator–activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells

Published:2020-07-17 Issue:10 Volume:83 Page:923-930
ISSN:1726-4901
Container-title:Journal of the Chinese Medical Association
language:en
Short-container-title:

Author:

Chen Jui-Yu,Wang Jane-Jen,Lee Hsin-Chen,Chi Chin-Wen,Lee Chen-Hsen,Hsu Yi-Chiung

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference20 articles.

1. Comparison of natural course between thyroid cancer nodules and thyroid benign nodules.;Yun;Endocrinol Metab (Seoul),2019

2. New developments in the diagnosis and treatment of thyroid cancer.;Schneider;CA Cancer J Clin,2013

3. Management of well-differentiated thyroid cancer.;Liao;Otolaryngol Clin North Am,2012

4. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013.;Lim;JAMA,2017

5. Differentiated thyroid carcinoma: defining new paradigms for postoperative management.;Durante;Endocr Relat Cancer,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics;Frontiers in Oncology;2024-07-15

2. Associations between Diabetes Mellitus and Selected Cancers;International Journal of Molecular Sciences;2024-07-08

3. Diabetes Mellitus and Thyroid Cancers: Risky Correlation, Underlying Mechanisms and Clinical Prevention;Diabetes, Metabolic Syndrome and Obesity;2024-02

4. Metabolic Reprogramming of Anti-cancer T Cells: Targeting AMPK and PPAR to Optimize Cancer Immunotherapy;Indian Journal of Clinical Biochemistry;2024-01-08

5. Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs;Frontiers in Pharmacology;2023-12-11